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Diagnostically untypeable subtypes contribute a considerable percent of hepatitis
C virus (HCV) subtypes in Pakistan. In the present study, chronically infected HCV
patients with known viremia were subjected to HCV genotyping. Among the total
retrieved samples, 92.7% (64/69) were found typeable while 7.24% (5/69) were
diagnostically untypeable. In conclusion, the presence of large number of untypeable
HCV subtypes emphasizes the need of an updated type-speciﬁc genotyping assay and
consideration of primers for proportionally rare subtypes to minimize the number of
untypeable HCV subtypes.
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Introduction
Hepatitis C is a leading infectious disease caused by hepatitis C virus
(HCV). HCV has been classiﬁed into genus hepacivirus, containing ssRNA of
9.6 kb. Globally, the anti-HCV prevalence is estimated to be greater than
180 million [1]. Pakistan carries the burden of about 10 million anti-HCV
cases [2].
Currently, HCV has six major genotypes and multiple subtypes. HCV
genotypes may vary in their acquisition route, therapy period, and response to
therapy [3]. Genotypes 1–3 are prevalent worldwide, genotype 4 is found in
Middle East, genotype 5 in South Africa while genotype 6 in Southeast Asia [2].
In Pakistan, genotype 3 occurs frequently while 3a is the most pervasive HCV
subtype followed by 3b, 1a, and a considerable proportion of diagnostically
untypeable subtypes [4]. To assess the latest proportion of diagnostically untypeable
*Corresponding author; E-mail: khan_ibge@yahoo.com
Acta Microbiologica et Immunologica Hungarica 63 (4), pp. 427–431 (2016)
DOI: 10.1556/030.63.2016.025
1217-8950/$ 20.00 © 2016 Akadémiai Kiado´, Budapest
HCV subtypes, a pilot study was conducted at the Institute of Biotechnology and
Genetic Engineering (IBGE), The University of Agriculture, Peshawar, Pakistan.
Methodology
The study design was duly approved from institutional ethical committee of
IBGE before commencement of the study. The present study was conducted
during April 2015–June 2015. Blood samples were collected from a total of 69
actively infected HCV patients. Collected blood samples were subjected to
genotyping assay for determination of HCV subtypes proportion by type-speciﬁc
primers using the previously described method [4].
Results and Discussion
It was identiﬁed that 92.75% (64/69) samples were HCV typeable subtypes
while 7.24% (5/69) were diagnosed as untypeable. Among the typeable subtypes,
44.92% (31/69) were found to be 3a, 21.73% (15/69) were 2a, 10.14% (7/69)
were 3b, 4.34% (3/69) were 1a, 2.89% (2/69) were 2b, 2.89% (2/69) were 1b,
1.44% (1/69) were genotype 4 while 4.34% (3/69) indicated mixed subtypes
(Figure 1). The mixed subtypes included 2.89% (2/69) as 3a/1b while 1.44%
(1/69) as 3a/3b. The untypeable subtypes have been previously reported from
different parts of the country in various studies [4–8] for their considerable share in
the overall HCV subtypes circulating in Pakistan (Table I). In general, the
Figure 1. Proportion of typeable (3a, 2a, 3b, 1a, 2b, 1b, 4, and mixed) and untypeable HCV subtypes
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polymerase chain reaction (PCR)-based HCV genotyping systems used in Paki-
stan relies on the method of Idrees [4] and Ohno et al. [9] developed in 2008 and
1997, respectively. Due to HCV high mutation rate of approximately 10−3 per
nucleotide per replication [10], host immune pressure [11], antivirals’ pressure
[12], and viral/host immune escape mechanism [13, 14], substantial quasi-species
population exists in HCV infected individuals. Some of these mutations may occur
in diagnostically important regions of the genome that results in mistyping of the
virus [15] which could lead to untypeable cases. Interestingly, in the present study,
1.44% (1/69) subtypes were identiﬁed as genotype 4. Although genotype 4 is rare
in Pakistan, a previous study [4] conﬁrmed its presence. However, in most
commercial laboratories and diagnostic centers, genotyping is performed for
subtypes 1a, 1b, 2a, 2b, 3a, and 3b, without including type-speciﬁc primers for
genotype 4 and subtypes 1c, 3c, 5a, and 6a despite their existence [4], which could
be a contributing factor to increased untypeable cases.
There is no deﬁnite treatment duration for untypeable subtypes as generally
therapy duration is assessed in terms of qualitative or quantitative detection (viral
load) [6]. In addition, the concept of “specialized therapies” for different HCV
genotypes is not common in Pakistan, which leads to increased cases of
non-responsiveness to treatment regimen [1]. Although the problem of untypeable
subtypes is not solely an issue of Pakistan, however, in a developed world, se-
quencing practice is a routine strategy for HCV genotyping. Research and commercial
laboratories that rely upon type-speciﬁc PCR as a tool for HCV genotyping have
limitation over time in the case of HCV [3]. Therefore, a large number of patients with
untypeable subtypes may face misdiagnosis and mistreatment.
Conclusion
Conclusively, substantial number of untypeable HCV subtypes was ob-
served in the present study. PCR-based genotyping system must be constantly
updated in light of local sequence data and type-speciﬁc primers for proportionally
rare subtypes should be included in the genotyping assay to avoid chances of
Table I. Untypeable subtypes proportion in different studies
Study Year Typeable HCV subtypes, % (n) Untypeable HCV subtypes, % (n)
Idrees 2008 93.84 (244) 6.15 (16)
Akhund et al. 2008 84.88 (292) 15.116 (52)
Ali et al. 2011 83 (166) 17 (34)
Inamullah et al. 2011 62.16 (115) 37.83 (70)
Waqar et al. 2014 87.82 (476) 12.17 (66)
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mistyping and mistreatment. The practice of sequencing should be made manda-
tory in the case of untypeable HCV subtypes for precise genotype identiﬁcation
and determination of treatment duration.
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